Our member @SnapBioSci achieved a milestone in developing several promising small molecule lead candidates with an outstanding selectivity profile for treatment of Hepatocellular carcinoma (HCC) and Hepatoblastoma together with @ChemDiv & @TorreyPinesInv. https://t.co/eBVSeXO0NZ
Excited to welcome @SnapBioSci into our i2020 Accelerator investment framework and Help Advance their Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases - https://t.co/9CWaKtZRGt #Cancer#autoimmunedisease#Collaboration
We are excited to join @i2020accelerat1 investment framework of @TorreyPinesInv . Together with @ChemDiv , we believe we will rapidly advance our selective kinase inhibitor program for treatment of endodermal cancers and autoimmune diseases. https://t.co/MkL1UzkJ8O